FDA recall D-0060-2021

PD-Rx Pharmaceuticals, Inc. · Class II · drug

Product

metformin HCL ER 750 mg Rx only Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 30 tablets NDC: 43063-902-30; b) 60 tablets NDC: 43063-902-60

Reason for recall

CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)

Distribution

AK, AZ, CA, CO, FL, GA, ID, IL, IN, KY, MN, NC, NY, OK, OR, WI

Key facts

Status
Terminated
Initiation date
2020-10-06
Report date
2020-11-11
Termination date
2021-10-22
Voluntary/Mandated
Voluntary: Firm initiated
Location
Oklahoma City, OK, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0060-2021